chrX-85278646-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_024921.4(POF1B):c.*775G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.009 in 110,759 control chromosomes in the GnomAD database, including 10 homozygotes. There are 255 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0090 ( 10 hom., 254 hem., cov: 22)
Exomes 𝑓: 0.0035 ( 0 hom. 1 hem. )
Consequence
POF1B
NM_024921.4 3_prime_UTR
NM_024921.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.964
Genes affected
POF1B (HGNC:13711): (POF1B actin binding protein) Premature ovarian failure (POF) is characterized by primary or secondary amenorrhea in women less than 40 years old. Two POF susceptibility regions called "POF1" and "POF2" have been identified by breakpoint mapping of X-autosome translocations. POF1 extends from Xq21-qter while POF2 extends from Xq13.3 to Xq21.1. This gene, POF1B, resides in the POF2 region. This gene is expressed at trace levels in mouse prenatal ovary and is barely detectable or absent from adult ovary, in human and in the mouse respectively. This gene's expression is restricted to epithelia with its highest expression in the epidermis, and oro-pharyngeal and gastro-intestinal tracts. The protein encoded by this gene binds non-muscle actin filaments. The role this gene may play in the etiology of premature ovarian failure remains to be determined. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-85278646-C-A is Benign according to our data. Variant chrX-85278646-C-A is described in ClinVar as [Benign]. Clinvar id is 368769.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POF1B | NM_024921.4 | c.*775G>T | 3_prime_UTR_variant | 17/17 | ENST00000262753.9 | NP_079197.3 | ||
POF1B | XM_005262203.5 | c.*775G>T | 3_prime_UTR_variant | 17/17 | XP_005262260.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POF1B | ENST00000262753 | c.*775G>T | 3_prime_UTR_variant | 17/17 | 1 | NM_024921.4 | ENSP00000262753.4 |
Frequencies
GnomAD3 genomes AF: 0.00906 AC: 1000AN: 110430Hom.: 11 Cov.: 22 AF XY: 0.00776 AC XY: 256AN XY: 32988
GnomAD3 genomes
AF:
AC:
1000
AN:
110430
Hom.:
Cov.:
22
AF XY:
AC XY:
256
AN XY:
32988
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00355 AC: 1AN: 282Hom.: 0 Cov.: 0 AF XY: 0.00909 AC XY: 1AN XY: 110
GnomAD4 exome
AF:
AC:
1
AN:
282
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
110
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00902 AC: 996AN: 110477Hom.: 10 Cov.: 22 AF XY: 0.00769 AC XY: 254AN XY: 33045
GnomAD4 genome
AF:
AC:
996
AN:
110477
Hom.:
Cov.:
22
AF XY:
AC XY:
254
AN XY:
33045
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Premature ovarian failure 2B Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at